Funded Tech Companies

ImmuneID

ImmuneID is a biopharmaceutical company, located in Cambridge. Financial backing was provided by Alexandria Venture Investments, Tekla Capital Management and Section 32.

Company Overview

Contact Information

Company Background Information

Overview

ImmuneID is a precision immunology company using its proprietary platform to simultaneously identify and therapeutically target millions of antibody interactions that drive immune diseases. We are employing our massively parallel, multiplexed, and unbiased systems to develop therapeutics for autoimmunity, severe allergy, oncology and infectious disease.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

6/24/2021

Financing History

Management Team

Title

Name

Email & Social

Chairman

Christoph Westphal

        

Chief Executive Officer

David Donabedian

        

Chief Financial Officer

Jeffrey Capello

        

President

Annalisa D'Andrea

        

Company Investors

• Alexandria Venture Investments
• Tekla Capital Management
• Section 32
• Longwood Fund
• Redwood Venture Partners
• Pitango Venture Capital
• Xfund
• Arch Venture Partners
• Alta Partners
• In-Q-Tel

Browse more funded tech companies:

Immunefi | Immunet

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary